PRESS RELEASE published on 02/22/2025 at 08:30, 1 year 5 months ago Communiqué de presse : ECCO 2025 : de nouvelles données sur le duvakitug illustrent son potentiel de meilleur médicament de sa catégorie pour le traitement de la colite ulcéreuse et de la maladie de Crohn Nouvelles données sur duvakitug présentées par Sanofi et Teva pour traiter colite ulcéreuse et maladie de Crohn au Congrès ECCO 2025, Berlin Maladie De Crohn Sanofi Colite Ulcéreuse Teva Duvakitug
PRESS RELEASE published on 02/22/2025 at 08:30, 1 year 5 months ago Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease Sanofi and Teva Pharmaceuticals present new detailed data from the RELIEVE UCCD study on duvakitug's efficacy in ulcerative colitis and Crohn's disease at ECCO 2025, demonstrating potential for phase 3 program in H2 2025 Ulcerative Colitis Sanofi Teva Pharmaceuticals Crohn's Disease RELIEVE UCCD Study
BRIEF published on 02/19/2025 at 07:35, 1 year 5 months ago Sanofi and CD&R Finalize Opella Share Purchase Agreement Share Purchase Regulatory Approvals Sanofi CD&R Opella
BRIEF published on 02/19/2025 at 07:35, 1 year 5 months ago Sanofi et CD&R finalisent l'accord d'achat d'actions d'Opella Achat D'actions Approbations Réglementaires Sanofi Opella CD-R
PRESS RELEASE published on 02/19/2025 at 07:30, 1 year 5 months ago Press Release: Sanofi and CD&R sign Opella share purchase agreement Sanofi and CD&R sign share purchase agreement for Opella, with Bpifrance as minority shareholder. Transaction expected to close in Q2 2025, subject to regulatory approvals Share Purchase Agreement Sanofi Bpifrance CD&R Opella
PRESS RELEASE published on 02/19/2025 at 07:30, 1 year 5 months ago Communiqué de presse : Sanofi et CD&R annoncent la signature de l’accord d’achat des actions d’Opella Sanofi et CD&R signent l’accord d’achat d’actions d’Opella. Bpifrance participe en tant qu'actionnaire minoritaire. Opération prévue au deuxième trimestre 2025 Acquisition Sanofi Bpifrance CD&R Opella
BRIEF published on 02/13/2025 at 20:13, 1 year 5 months ago Sanofi Files 2024 Financial Reports with SEC and AMF Financial Report 2024 SEC Filing Sanofi AMF Compliance
BRIEF published on 02/13/2025 at 20:13, 1 year 5 months ago Sanofi dépose ses rapports financiers 2024 auprès de la SEC et de l'AMF Rapport Financier 2024 Sanofi Dépôt Auprès De La SEC Conformité AMF
PRESS RELEASE published on 02/13/2025 at 20:08, 1 year 5 months ago Press Release: Filing of the 2024 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report Sanofi files 2024 U.S. Form 20-F and French Annual Financial Report. Documents available online. Company focused on healthcare innovation Innovation Financial Report Healthcare Form 20-F Sanofi
PRESS RELEASE published on 02/13/2025 at 20:08, 1 year 5 months ago Communiqué de presse : Dépôt du Document d’Enregistrement Universel 2024, contenant le Rapport Financier Annuel, et du « Form 20-F » américain Sanofi dépose son Document d’Enregistrement Universel 2024 et le « Form 20-F » américain, incluant le Rapport Financier Annuel et des informations clés, pour consultation en ligne AMF Rapport Financier Annuel Form 20-F Sanofi Document D’Enregistrement Universel 2024
Published on 08/12/2026 at 15:42, 4 hours 17 minutes ago Critical Elements 10,000-Meter Summer Drill Program at Rose West Resumes with Positive Results
Published on 08/12/2026 at 15:42, 4 hours 17 minutes ago Critical Elements redémarre son programme de forage estival de 10 000 mètres à Rose Ouest avec des résultats positifs
Published on 08/12/2026 at 15:00, 4 hours 59 minutes ago Karbon-X and Core Energy Sign Letter of Intent to Explore Commercial EV Charging Infrastructure in South America
Published on 08/12/2026 at 14:45, 5 hours 14 minutes ago Lobe Sciences Ltd. Announces Non-Brokered Private Placement
Published on 08/12/2026 at 19:37, 21 minutes ago EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for H1 2026 at €13.4 million and adjusted EBITDA at €-0.5 million; forecast for the continuing operations unchanged
Published on 08/12/2026 at 18:17, 1 hour 42 minutes ago EQS-Adhoc: Gateway Real Estate AG resolves segment change from the regulated market (Prime Standard) to the Scale segment of the open market (Freiverkehr) on the Frankfurt Stock Exchange
Published on 08/11/2026 at 17:45, 1 day 2 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 2 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 1 hour ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 1 hour ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026